VTN and neoplasm: Since tumor cells and stromal cells both generate abnormal complement proteins, the TME’s complement system becomes aberrantly activated, promoting tumor development by curbing inflammation, stromal cell immunity, and tumor cell expansion, epithelial-mesenchymal transition (EMT), migration, and metastatic spread (51, 52).